Nanosphere, Inc. (NASDAQ:NSPH) was founded in 1998 and is headquartered in Northbrook, Illinois, USA. It is a medical laboratory and research institution focusing on the development of genetic and protein molecular diagnostic platforms.
Nanosphere Inc. (NSPH):
Nanosphere, Inc. is engaged in the development, production and sales of molecular diagnostic tests for early disease detection, optimizing patient treatment and improving the economics of healthcare. Nanosphere Medical Corporation provides a “Verigene System” molecular diagnostic platform that enables clinicians to identify and treat infectious diseases that are complicated, costly, and fatal bacterial and viral infections. The system includes an experimental benchtop molecular diagnostic workstation for detecting genomes and proteins, which is used to detect infectious disease analysis, human and pharmacogenetics analysis, and highly sensitive protein analysis.
Nanosphere mainly serves hospital laboratories and academic research institutions in the United States. It was listed on Nasdaq in 2007 with an IPO.